PXMD — PaxMedica Income Statement
0.000.00%
Last trade - 00:00- $0.01m
- -$0.31m
Annual income statement for PaxMedica, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.599 | 5.64 | 7.14 | 11.2 | 16.2 |
| Operating Profit | -0.599 | -5.64 | -7.14 | -11.2 | -16.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.599 | -7.83 | -10.2 | -14.8 | -18.3 |
| Net Income After Taxes | -0.599 | -7.83 | -10.2 | -14.8 | -18.3 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.599 | -7.83 | -10.2 | -14.8 | -18.3 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.634 | -9.3 | -10.2 | -14.8 | -18.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.916 | -13.3 | -14.8 | -20.1 | -11 |
| Dividends per Share |